Fresh Tracks Therapeutics (formerly known as Brickell Biotech) is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated therapeutics for the treatment of skin diseases. Its therapeutics focuses on hyperhidrosis, allergic contact dermatitis, acne, psoriasis, atopic dermatitis, and androgenic alopecia, enabling medical companies to offer a rapid and cost-effective product. The company merged with Vical.